More business action with big pharma and the biotech industry, although Roche and Genentech already are invested together and have worked on conjunction on research projects. Roche acquired a majority in Genentech in 1990 and currently owns 55.9% of all outstanding shares. Roche...
Posted to
The Medical Quack .... by Barbara Duck
on 07-21-2008
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, Pharma, Pharmacogenomics, Bio Tech, Genentech, Roche